http://id.medscape.com/reuters/prof/2001/12/12.05/20011204publ001.html
|
Early Two-Dose
Measles Vaccination Deemed Useful in Endemic Areas WESTPORT, CT (Reuters Health) Dec 04 - An early
two-dose measles vaccination schedule can improve vaccination coverage in
areas at high risk of measles among infants, according to an analysis of the
schedule's impact in Dade County, Florida. "Our findings...support the Advisory Committee on Immunization
Practices recommendation to use this schedule when the risk of measles is
high among infants," Dr. Sonja S. Hutchins, of the Centers for Disease
Control and Prevention in Atlanta, and a multicenter team conclude in the
December 1st issue of the American Journal of Epidemiology. The investigators examined the impact of vaccinating infants at 6 months
and again at 12-15 months by assessing coverage, humoral immunity and
clinical protection before and after the schedule was first instituted in
Dade County to control a large measles epidemic in 1986 to 1987. Vaccination coverage among 2-year-olds increased from 75% before the
implementation of the early schedule to 94% in 1996. Seroprevalence of plaque
reduction neutralization antibody among children age 4 to 6 years in 1995 was
similar between children who received the early two-dose vaccination schedule
and those who received a single dose of the vaccine at or after 12 months of
age. And clinical protection was high in both groups, at 99.5% and 99.7%,
respectively. "Our study suggests that an early two-dose measles vaccination
schedule in high-risk areas of Dade County was effective in preventing and
controlling measles in the community," Dr. Hutchins and others say in
the report. "Implementation of this schedule was associated with a
reduction in measles morbidity and mortality," they add, with no
reported increase in vaccine side effects. Measles cases also shifted from
younger to older children after implementation of the schedule, and endemic
transmission ended after 1993. The team concludes that the early two-dose measles vaccination schedule is
a safe and effective way to improve vaccine coverage and reduce measles
morbidity and mortality in areas at high risk of measles in infants. Am J Epidemiol 2001;154:1064-1071.
|
|
|
|||||
|
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.